Company intelligence / Profile preview

Sera Prognostics

Salt Lake City, Utah, United Statesinvestors.seraprognostics.com ↗

Ownership: Public · SERA
Employees: ~64
Development stage: Commercial

Overview

Sera Prognostics has commercialized the PreTRM® Test, a first-of-kind blood-based diagnostic that predicts an individual pregnant woman's risk of spontaneous preterm delivery. Clinical studies have demonstrated its ability to identify at-risk women earlier than standard care. The company continues to develop additional tests targeting other major pregnancy complications such as preeclampsia and fetal growth restriction. Its LikeMine™ digital platform leverages large-scale pregnancy data for personalized insights.

Therapeutic areas: Women's Health
Modalities: Diagnostic test (blood-based biomarker)Predictive analytics product/servicePlatform (biomarker discovery and risk prediction)
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

PreTRM Test

Commercial

Indications: Premature birth risk assessment, Pregnancy complications

Financials

Market cap: $76.8M
Total revenue: $30K
Enterprise value: $33.3M

Beyond the preview

Go deeper on Sera Prognostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sera Prognostics.

Explore the full profile